The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin

European Journal of Immunology

Volumn 28, Issue 12, 1998, Pages 4130-4137

  Bopst, Martin ^a,e   Haas, Cordula ^b   Car, Bruce ^c   Eugster, Hans Pietro ^d  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c DUPONT COMPANY   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UCB PHARMA   (Belgium)

Author keywords

Acute phase response; Cytokine; Serum amyloid A; Serum amyloid P; TNF

Indexed keywords

ACUTE PHASE PROTEIN; ENDOTOXIN; GLUCOSE; HAPTOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; TURPENTINE;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031770199     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199812)28:12<4130::aid-immu4130>3.0.co;2-w     Document Type: Article

References (40)

1. Ramadori, G., Sipe, J. D., Dinarello, C. A., Mizel, S. B. and Colten, H. R., Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J. Exp. Med. 1985. 162: 930-942.
2. Andus, T., Geiger, T., Hirano, T., Kishimoto, T. and Heinrich, P. C., Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins. Eur. J. Immunol. 1988. 18: 739-746.
3. Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. J. and O'Connor, J. V., Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 1986. 163: 1433-1450.
4. Ramadori, G., Van, D. J., Rieder, H. and Meyer zum Büschenfelde, K.-H., Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur. J. Immunol. 1988. 18: 1259-1264.
5. Dinarello, C. A., Interleukin-1 and the pathogenesis of the acute-phase response. N. Engl. J. Med. 1984. 311: 1413-1418.
6. Ritchie, D. G. and Fuller, G. M., Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein. Ann. NY Acad. Sci. 1983. 408: 490-502.
7. Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P. and Espevik, T., The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 1989. 169: 333-338.
8. Waage, A., Brandtzaeg, P., Espevik, T. and Halstensen, A., Current understanding of the pathogenesis of gram-negative shock. Infect. Dis. Clin. North. Am. 1991. 5: 781-791.
9. Fong, Y., Moldawer, L. L., Marano, M. et al., Endotoxemia elicits increased circulating beta 2-IFN/IL-6 in man. J. Immunol. 1989. 142: 2321-2324.
10. Moldawer, L. L., Gelin, J., Schersten, T. and Lundholm, K. G., Circulating interleukin 1 and tumor necrosis factor during inflammation. Am. J. Physiol. 1987. 253: R922-928.
11. Baumann, H. and Gauldie, J., The acute phase response [see comments]. Immunol. Today 1994. 15: 74-80.
12. Kushner, I., The phenomenon of the acute phase response. Ann. NY Acad. Sci. 1982. 389: 39-48.
13. Hilliquin, P., Biological markers in inflammatory rheumatic diseases. Cell. Mol. Biol. 1995. 41: 993-1006.
14. Steel, D. M. and Whitehead, A. S., The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 1994. 15: 81-88.
15. Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P. and Poli, V., Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 1994. 180: 1243-1250.
16. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. and Köhler, G., Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994. 368: 339-342.
17. Zheng, H., Fletcher, D., Kozak, W. et al., Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity 1995. 3: 9-19.
18. Leon, L. R., Conn, C. A., Glaccum, M. and Kluger, M. J., IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice. Am. J. Physiol. 1996. 271: R1668-1675.
19. Tocci, M. J., Structure and function of interleukin-1 beta converting enzyme. Vitam. Horm. 1997. 53: 27-63.
20. Pfeffer, K., Matsuyama, T., Kundig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Kronkem, M. and Mak, T. W., Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993. 73: 457-467.
21. Eugster, H. P., Muller, M., Karrer, U., Car, B. D., Schnyder, B., Eng, V. M., Woerly, G., LeHir, M., di Padova, F., Aguet, M., Zinkernagel, R., Bluethmann, H. and Ryffel, B., Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. Int. Immunol. 1996. 8: 23-36.
22. Korner, H., Cook, M., Riminton, D. S., Lemckert, F. A., Hoek, R. M., Ledermann, B., Kontgen, F., Fazekas de St. Groth, B. and Sedgwick, J. D., Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 1997. 27: 2600-2609.
23. Marino, M. W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., Basu, S. and Old, L. J., Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 1997. 94: 8093-8098.
24. Benigni, F., Fantuzzi, G., Sacco, S., Sironi, M., Pozzi, P., Dinarello, C. A., Sipe, J. D., Poli, V., Cappelletti, M., Paonessa, G., Pennica, D., Panayotatos, N. and Ghezzi, P., Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 1996. 87: 1851-1854.
25. Gershenwald, J. E., Fong, Y. M., Fahey, T. D., Calvano, S. E., Chizzonite, R., Kilian, P. L., Lowry, S. F. and Moldawer, L. L., Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA 1990. 87: 4966-4970.
26. Strassmann, G., Fong, M., Windsor, S. and Neta, R., The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 1993. 5: 285-290.
27. Oldenburg, H. S., Rogy, M. A., Lazarus, D. D., Van, Z. K., Keeler, B. P., Chizzonite, R. A., Lowry, S. F. and Moldawer, L. L., Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur. J. Immunol. 1993. 23: 1889-1894.
28. Billiar, T. R., Curran, R. D., Williams, D. L. and Kispert, P. H. Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote localized inflammation. Arch. Surg. 1992. 127: 31-36.
29. Luheshi, G. N., Stefferl, A., Turnbull, A. V., Dascombe, M. J., Brouwer, S., Hopkins, S. J. and Rothwell, N. J., Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-alpha in the rat. Am. J. Physiol. 1997. 272: R862-868.
30. Leon, L. R., Kozak, W., Peschon, J. and Kluger, M. J., Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice. Am. J. Physiol. 1997. 272: R563-569.
31. Fantuzzi, G., Zheng, H., Faggioni, R., Benigni, F., Ghezzi, P., Sipe, J. D., Shaw, A. R. and Dinarello, C. A., Effect of endotoxin in IL-1 beta-deficient mice. J. Immunol. 1996. 157: 291-296.
32. Fantuzzi, G. and Dinarello, C. A., The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice. J. Leukoc. Biol. 1996. 59: 489-493.
33. Elliott, M. J., Maini, R. N., Feldmann, M. et al., Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis. Rheum. 1993. 36: 1681-1690.
34. Husebekk, A., Skogen, B., Husby, G. and Marhaug, G., Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand. J. Immunol. 1985. 21: 283-287.
35. Glenner, G. G., Amyloid deposits and amyloidosis. the beta-fibrilloses (first of two parts). N. Engl. J. Med. 1980. 302: 1283-1292.
36. Kalaria, R. N., Galloway, P. G. and Perry, G., Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Neuropathol. Appl. Neurobiol. 1991. 17: 189-201.
37. Duong, T., Pommier, E. C. and Scheibel, A. B., Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol. 198. 78: 429-437.
38. Laurell, C. B., Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochem. 1966. 15: 45-52.
39. Baumann, H., Electrophoretic analysis of acute-phase plasma proteins. Methods Enzymol. 1988. 163: 566-494.
40. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987. 162: 156-159.